Intervensi koroner perkutan pada infark miokard akut disertai elevasi segmen ST awitan lebih dari 12 jam dengan penyulit syok kardiogenik
- PDF |
- DOI: https://doi.org/10.15562/ism.v8i2.114 |
- Published: 2017-05-08
Open Access & Peer Reviewed
Multidisciplinary Journal of Science and
Medical Research
Multidisciplinary Journal of Science and
Medical Research
Abstract
Background: Percutaneous coronary intervention (PCI) is the primary therapy in patients with acute myocardial infarction with-ST Segment Elevation (AMI-STE) in the first 12 hours of onset of symptoms. However PCI still needs to be done in patients with onset more than 12 hours who still showed prolonged ischemia process. Case: A man, 49 years old came to the emergency room Central Army Hospital Gatot Subroto (RSPAD) with chest pain typically infarction angina since 6 days ago. Patient was referred from Islamic Hospital with anterior AMI-STE-onset 2 hours TIMI 7/14 Killip Class IV without revascularization and acute renal failure. Patient determined to be referred after treated in ICVCU Islamic Hospital, but patient had a progressive chest pain and hemodynamic disturbances. After revascularization in the RSPAD Hospital, clinical and hemodynamic conditions of this patient slowly improved. Discussion: Reperfusion therapy should be given if there is clinical evidence or evidence which showed prolonged ischemic ECG, even if the patient according to the symptoms have lasted more than 12 hours. It is because the onset of actual attack is certainly known. AMI-STE guidelines by ESC and AHA also recommend PCI procedure in patients with signs of prolonged ischemia process. Conclusion: Revascularization in patients with AMI-STE onset more than 12 hours should be performed in patients who still show a prolonged ischemia process and hemodynamic disturbances.
Keywords:
Acute myocardial infarction
ST elevation
Primary percutaneous intervention
Cardiogenic shock
References
- Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619.
- Zarrabi A, Eftekhari H, Casscells SW, Madjid M. The open-artery hypothesis revisited. Texas Hear Inst J. 2006;33(3):345–52.
- Cohen M, Boiangiu C, Abidi M. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy. J Am Coll Cardiol. 2010;55(18):1895–906.
- PG S, C T, Himbert D. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J. 2004;25(24):2187–94.
- Schömig A, Mehilli J, Antoniucci D. Beyond 12 hours reperfusion alternative evaluation (BRAVE-2) trial. J Am Med Assoc. 2005;293(23):2865–72.w
- Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: A report from the cathpci registry. JACC. Elsevier; 2016;9(4):341–51.
- Bahekar A, Singh M, Singh S, Bhuriya R, Ahmad K, Khosla S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. Joournal Cardiovasc Pharmacol Ther. 2012;17(1):44–56.
- Departemen Kesehatan Republik Indonesia. Riset Kesehatan Dasar. 2007.
- Gershlick AH, Khan JN, Kelly DJ. Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease. JACC. 2015;65(10):963–72.
- Angiolillo D, Bass T. Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction: Shifting Paradigms and Future Perspectives. Circulation: Cardiovascular Interventions. 2013;6(6):593-595.
How to Cite
Dwipawana, I. G. B. A., Pratama, V., & Callista, M. A. (2017). Intervensi koroner perkutan pada infark miokard akut disertai elevasi segmen ST awitan lebih dari 12 jam dengan penyulit syok kardiogenik. Intisari Sains Medis, 8(2), 93–96. https://doi.org/10.15562/ism.v8i2.114
